# clm_3322844F3158

subject: Novo Nordisk (/record/novo-nordisk.md)  
predicate: total_equity  
value: 51,839,000,000 DKK  
valid_from: 2018-12-31  
valid_to: 2019-12-31  
published: 2022-02-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_43C7BF9EE087  
last_updated: 2026-11-08  
cite: AsOf. "Novo Nordisk total equity: 51,839,000,000 DKK", as of 2018-12-31 (until 2019-12-31). Claim clm_3322844F3158, https://asof.is/claim/clm_3322844F3158, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: ifrs-full:Equity in 20-F FY2021, filed 2022-02-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/0001628280-22-001639-index.htm (primary, SEC EDGAR 20-F FY2021, published 2022-02-02)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.